Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Subjects

NCT01295320 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01295320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01295320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Subjects
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2011
Completion date
June 20, 2013
Enrollment
129 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster